smart drugs, new therapies & The Cancer Treatment Revolution
cancer research journal

Cancer Research Journal Article

More Dutch Cancer Patients Dying Under Deep Sedation

rates in the are on the decline as more elect to die under .

According to a study led by researchers at in , the use of continuous deep sedation rose from 5.6 percent in all deaths in 2001 to 7.1 percent in 2005 resulting in an increase of about 1,800 cases. During the same period, the use of euthanasia (a practice which is legal in the Netherlands, but not in the US) dropped from 2.6 percent to 1.7 percent of all deaths – a decrease of approximately 1,200 cases.

Most of the deep sedation increases occurred among being treated by without consultation from palliative care experts.

The researchers noted that approximately 10 percent of the patients who died under continuous deep sedation had asked for euthanasia, but their requests had been denied. As one US palliative care specialist who wrote an editorial on the study said,

“We don’t know if continuous deep sedation is being used as a substitute for euthanasia or whether it is indicative of better care for people who would otherwise die in distress.”


Director of ,

To arrive at their findings, the research team analyzed data on 6,860 deaths that occurred in the Netherlands between August and November 2005. Results of their research have been in the March 14, 2008, online edition of the .

If you’d like to learn more about end-of-life care options available to patients in the United States, you can .

Source:

Related Links: ; ; ;

Technorati Tags: ; ; ; ; ; ;


Print This Print This   |     |   Sphere: Related Content

1 Comment »

  1. Pingback by Helping change the law in Washington State | Assisted-Suicide Blog — April 25, 2008 @ 12:52 pm

    [...] More Dutch Cancer Patients Dying Under Deep Sedation | Cancer Research Journal on Luxemburg passes euthanasia law — follows Holland and Belgium [...]

RSS feed for comments on this post. TrackBack URI

Leave a comment


Published by Lisa on Monday 24 March 2008 at 1:11 pm - permalink
Filed under Palliative and Hospice, Programs and Initiatives

Browse All Categories:   

Next article: BBC to Broadcast Brain Surgery Done with 65-Dollar Drill
Previous article: Scientists Try to Protect Patients from Untested Treatments


  white spacer

More News and Information for Cancer Patients, Medical Professionals and Legislators

white spacer

Cancer Research Bookmarks

US Surgeon General - Childhood Obesity Prevention Initiative for Schools and Teachers

Department of Health and Human Services site that provides resources for teachers and administrators wanting to improve fitness and nutrition programs in their schools. Contains success stories from other successful programs, links to statistics, and tip

caBIG™ Community Website

Cancer Biomedical Informatics Grid from NCI. Portal for a networking initiative to share information about cancer research. Contains newsletters and updates on programs to connect the cancer community.

American College of Physicians - Patient Education and Caring End-of-Life Series

Free ACP guides of interest to patients and families dealing with advanced cancer. Includes useful information on pain management, palliative care, etc.

Wall Street Journal - Health Blog

Informative blog that carries interesting articles about medicine, cancer and health initiatives. Recent features include stories related to electronic health records, retail health clinics and drug safety.

RESOLVE: The National Infertility Association: Surrogacy

Contains a list of useful questions couples considering surrogacy may want to consider. A valuable resource for some patients whose cancer treatments have left them infertile.

Social Innovation Conversations

A Conversation Network channel (a listener-supported nonprofit that features pieces on innovation, collaboration, IT, social and health initiatives, etc. Editorial team led by Stanford's Center for Social Innovation

OnGuard Online - Videos and Tutorials

US government site that provides practical tips to help internet users surf safely. Contains free video tutorials about how to avoid phishing scams, identity theft, etc. A useful resource for those who spends time on the internet shopping or looking for

more del.icio.us bookmarks...

Recent Cancer Research Articles

Walk-In Cervical Cancer Screening Works Well in Canada

Doctors in British Columbia tested a program giving women an opportunity to get Pap tests without appointments. It was so successful, they’re expanding it.

First Head and Neck Cancer Gene Therapy Faces FDA Review

A Texas-based biotech becomes the first company to seek FDA approval for a gene-based cancer drug. This one is designed to treat recurrent head and neck cancer.

All UK Cancer Patients Will Get Information on Clinical Trials

To boost recruiting and improve awareness, government officials in the United Kingdom plan to routinely inform all NHS cancer patients about clinical trials.

Berkeley Microarray Makes Cancer Diagnosis Less Costly

Scientists at DOE’s Berkeley National Lab develop a new way to screen DNA and RNA. Their technique could make cancer testing and research faster AND cheaper.

Parents Seek Organ Donors Using Social Networking

Two young parents with a terminally-ill child turn to Facebook to find an organ donor. They’re not only finding support, they’re raising a lot of awareness.

Cuba Approves CimaVax EGF Vaccine for Lung Cancer

Health officials in Havana announce they’ve approved the first vaccine for treating lung cancer but, travel restrictions may keep US patients from using it.

MD Anderson and Duke Help Breast Cancer Survivors and Their Daughters Drop Weight

Two top medical institutions team up to help breast cancer survivors and their daughters get healthier. See what it takes to participate in the free program.


Search All Articles:  

Get CancerResearchJournal.com delivered to your feed reader or browser.

Peer-Reviewed Journals

DEVELOPMENT: Coordinated Growth
Science - Editor's Choice - 07/04/2008

Conferences in the nanoworld
Nature Nanotechnology - 07/04/2008

Lost in translation—prognostic signatures for breast cancer
Nature Clinical Practice Oncology - 07/04/2008

Photoluminescence from intermediate phase silicon structure and nanocrystalline silicon in plasma enhanced chemical vapor deposition grown Si/SiO2 multilayers
Nanotechnology - 07/03/2008

Defining the blueprint of the cancer genome
Carcinogenesis - 07/03/2008

[NEWS & VIEWS] GENETIC PREDICTOR OF LUNG CANCER RISK
CA - 07/02/2008

IN THIS ISSUE
Journal of the National Cancer Institute - 07/01/2008

Editorial
Briefings in Functional Genomics and Proteomics - 06/30/2008

Editorial
Bioinformatics - 06/27/2008

New methods for assessing male germ line mutations in humans and genetic risks in their offspring
Mutagenesis - 06/27/2008

Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease
Human Molecular Genetics - 06/27/2008

In this issue
Annals of Oncology - 06/25/2008

Treatment of Patients with Clinically Lymph Node-negative Squamous Cell Carcinoma of the Oral Cavity
Japanese Journal of Clinical Oncology - 06/23/2008

Editorial
Health Policy and Planning - 06/18/2008


Cancer Research Journal supports taxpayer access.

white spacer

Latest Cancer Research Journal Comments


Comment on Cuba Approves CimaVax EGF Vaccine for Lung Cancer by Lisa

Thank you to Kevin for sharing his research with our readers. The vaccine is not currently FDA approved for marketing here in the United States so I cannot offer any assistance on where to purchase/obtain it other than the information already provided in the article. As of today, the only country who is offering the drug outside of clinical trials is Cuba. Peru is predicted to approve it next, but that has yet to be finalized. We wish you all the best and invite anybody else with information on this topic to join in the discussion. Thank you and take care.

Comment on Cuba Approves CimaVax EGF Vaccine for Lung Cancer by Sudarshan R. Chetlur

Dear Sir, One of my very close relations is suffering from Lung Cancer. The doctors say that he is in advance stage. He lives in Calicut (in Kerala, India). He is undergoing Chemo and was first given Gemcitabine (Gemcite) and is now on Doceterust. Please advise How can avail CIMAVAX in India. We would be greatful for all the information and help you provide. Very anxiuosly waiting for a response from your side and thanking you from the heart... Sudarshan R. Chetlur

Comment on Cuba Approves CimaVax EGF Vaccine for Lung Cancer by Kevin Felix

I have done extensive website research for my gf who's father has cancer in Brazil and for the Vinh Le in Canada I can tell you that YM Bioscience has the permit currently for North America and if you check their website at http://www.ymbiosciences.com/main.cfm?docID=22 you will see they have a strategic partnership with the Centre of Molecular Immunology (University of Havana, Cuba). CancerVAC had the permit for North America but went bankrupt so now YMBio now has it. They also have a a license agreement for their products with University of Manitoba (Canada) so you may contact them and be able to get more/better info. The latest according to the Doctor who developed it says a price has not been set (even though licenses have been issued to companies) but that foreigners are welcome to come to Cuba for treatment if financially possible course. Aslo from another story that "YM BioSciences of Canada may handle distribution in North America and Europe." Latest I have found is that Peru is next to possibly gain approval and that may not be until the end of the year. Hope this helps any at all.

more comments...

Cancer Research Journal is a about emerging innovations in the worldwide fight against cancer. We advocate the use of techniques and
philosophies to help accelerate the sharing of information for cancer patients, medical professionals and legislators. Click here to learn more.

Cancer Research Journal is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Site built by Content Developer using Wordpress. Site published under a Creative Commons Attribution-Share Alike 3.0 United States License.